Johnson & Johnson (NYSE:JNJ)’s traded shares stood at 20.29 million during the last session, with the company’s beta value hitting 0.54. At the close of trading, the stock’s price was $152.38, to imply a decrease of -1.07% or -$1.65 in intraday trading. The JNJ share’s 52-week high remains $186.69, putting it -22.52% down since that peak but still an impressive 1.1% since price per share fell to its 52-week low of $150.71. The company has a valuation of $395.87B, with an average of 7.81 million shares in intraday trading volume over the past 10 days and average of 7.64 million shares over the past 3 months.
Analysts have given a consensus recommendation of an Overweight for Johnson & Johnson (JNJ), translating to a mean rating of 2.50. Of 20 analyst(s) looking at the stock, 0 analyst(s) give JNJ a Sell rating. 3 of those analysts rate the stock as Overweight while 11 advise Hold as 5 recommend it as a Buy. 1 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at $2.52.
Do You Know The Best Place To Find Gains In Volatile Markets?
In today's chaotic marketplace, the biggest gains will come from some currently-small companies that pass by older, larger businesses still stuck in a pre-pandemic world. The trick is figuring out which small caps will be tomorrow's winners. That's why StockWire News has put together a special Wealth Building Report, highlighting 3 small cap stocks set to soar in 2023.
Click here for full details and to join for free.
Johnson & Johnson (NYSE:JNJ) trade information
After registering a -1.07% downside in the last session, Johnson & Johnson (JNJ) has traded red over the past five days. The stock hit a weekly high of 155.91 this Friday, 03/17/23, dropping -1.07% in its intraday price action. The 5-day price performance for the stock is 0.51%, and -4.39% over 30 days. With these gigs, the year-to-date price performance is -13.74%. Short interest in Johnson & Johnson (NYSE:JNJ) saw shorts transact 9.17 million shares and set a 1.14 days time to cover.
Analysts on Wall Street suggest a consensus price target of $180.95, implying an increase of 15.79% to the stock’s current value. The extremes give us $161.00 and $215.00 for target low and target high price respectively. As such, JNJ has been trading -41.09% off suggested target high and -5.66% from its likely low.
Johnson & Johnson (JNJ) estimates and forecasts
Looking at statistics comparing Johnson & Johnson share performance against respective industry, we note that the company has outperformed competitors. Johnson & Johnson (JNJ) shares are -7.69% down over the last 6 months, with its year-to-date growth rate higher than industry average at 3.45% against -4.00%. Revenue is forecast to shrink -5.60% this quarter before jumping 0.80% for the next one. The rating firms project that company’s revenue will grow 3.10% compared to the previous financial year.
Revenue forecast for the current quarter as set by 13 analysts is $23.67 billion. Meanwhile, for the quarter ending Jun 2023, a total of 13 analyst(s) estimate revenue growth to $24.51 billion.Earnings reports from the last fiscal year show that sales brought in $23.43 billion and $24.02 billion respectively in the corresponding quarters. In this case, analysts estimate current quarter sales to rise 1.10% before jumping 2.10% in the following quarter.
An assessment of the company’s 5-year growth patterns shows that annual earnings grew an estimated 5.30% for the past 5-year period. While 2023 is set for a -13.70% return in earnings, projections for the next 5 years are at 3.94% annually.
Johnson & Johnson has its next earnings report out on April 18. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too. Johnson & Johnson has a forward dividend ratio of 4.52, with the share yield ticking at 2.97% to continue the rising pattern observed over the past year. The company’s average dividend yield trailing the past 5-year period is 0.00%.
Johnson & Johnson (NYSE:JNJ)’s Major holders
Johnson & Johnson insiders hold 0.09% of total outstanding shares, with institutional holders owning 70.93% of the shares at 70.99% float percentage. In total, 70.93% institutions holds shares in the company, led by Vanguard Group, Inc. (The). As of Sep 29, 2022, the company held over 245.34 million shares (or 9.38% of shares), all amounting to roughly $40.08 billion.
The next major institution holding the largest number of shares is Blackrock Inc. with 199.89 million shares, or about 7.65% of shares outstanding. As of the market price on Sep 29, 2022, these shares were worth $32.65 billion.
We also have Vanguard Total Stock Market Index Fund and Vanguard 500 Index Fund as the top two Mutual Funds with the largest holdings of the Johnson & Johnson (JNJ) shares. Going by data provided on Sep 29, 2022, Vanguard Total Stock Market Index Fund holds roughly 78.44 million shares. This is just over 3.00% of the total shares, with a market valuation of $12.81 billion. Data from the same date shows that the other fund manager holds a little less at 59.6 million, or 2.28% of the shares, all valued at about 9.74 billion.